Arrhythmia Research Technology Inc. (HRT)
-NYSE MKT 2.52 
0.02(0.80%) 3:59PM EDT
| Prev Close: | 2.50 |
|---|
| Open: | 2.55 |
|---|
| Bid: | 1.86 x 200 |
|---|
| Ask: | 2.95 x 300 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 1.63 |
|---|
| Next Earnings Date: | 20-May-13 |
|---|
| Day's Range: | 2.51 - 2.55 |
|---|
| 52wk Range: | 1.89 - 3.34 |
|---|
| Volume: | 1,750 |
|---|
| Avg Vol (3m): | 4,789 |
|---|
| Market Cap: | 7.03M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -2.12 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ FinancialsEDGAR Online Financials(Fri, May 17)
- Arrhythmia Research Technology, Inc. Announces Delay in Finalizing First Quarter of 2013 ResultsMarketwired(Fri, May 17)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Tue, May 14)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K/A, Results of Operations and Financial Condition, FinanciaEDGAR Online(Wed, May 1)
- Arrhythmia Research Technology, Inc. Receives NYSE MKT Exchange Compliance NoticeMarketwired(Tue, Apr 23)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued LisEDGAR Online(Tue, Apr 23)
- Arrhythmia Research Technology, Inc. Announces Delay in Finalizing Fourth Quarter and 2012 Year End ResultsMarketwired(Wed, Apr 17)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Thu, Apr 11)
- Arrhythmia Research Technology, Inc. Announces New President and Chief Executive OfficerMarketwired(Tue, Apr 9)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Wed, Apr 3)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Fri, Mar 29)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of aEDGAR Online(Fri, Mar 15)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ FinancialsEDGAR Online Financials(Wed, Nov 28)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, FinancialEDGAR Online(Tue, Nov 27)
- ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, Nov 23)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 0.33 |
|---|
| Ex-Dividend Date: | 13-Feb-12 |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Arrhythmia Research Technology, Inc., through its subsidiaries, manufactures components, devices, and equipment primarily for the medical and defense industries.
View More